Medley stock came into this earnings print riding strong momentum, up roughly a quarter over the past month, and already priced on a rich P/E of 44.3x. The headline today is a sharp swing back into profitability, with Q2 basic earnings per share at ¥51.58 on revenue of ¥12,494m. That kind of earnings reset can make an already emotional trade even more charged, especially when the company is carrying high debt and margins are only modestly above last year. The question now is whether this quarter steadies sentiment or simply raises the bar.
Impressed by Medley's earnings rebound but uneasy about that rich P/E and high debt load? Compare this setup with our 60 resilient stocks with low risk scores.
Q2 2026 Earnings Summary
- Revenue (Q2 2026 vs. Q2 2025): ¥12,494m vs. ¥10,325m (up about 21%)
- Net Income (Q2 2026 vs. Q2 2025): ¥1,559m vs. ¥722m (up about 116%)
- Basic EPS (Q2 2026 vs. Q2 2025): ¥51.58 vs. ¥22.36 (up about 131%)
- Trailing 12M Basic EPS (Q2 2026 vs. Q2 2025): ¥59.15 vs. ¥69.55 (down about 15%)
Prefer clear visuals instead of another wall of earnings tables and footnotes? View Medley's complete financial picture, with a focus on its valuation, in an easy-to-use dashboard through the company report for Medley.
Medley bullish signals from earnings momentum
For investors leaning positive on Medley, this quarter gives some support. Revenue of ¥12,494m and net income of ¥1,559m both sit well above the prior year period, and basic EPS more than doubled to ¥51.58. That shift back into profit fits a digitizing healthcare story where scale can matter. The share price has also risen over the past 7, 30 and 90 days, which indicates the market is rewarding this earnings reset, at least for now.
Medley risks highlighted by profit mix and debt
The cautious side of the Medley story still has some backing. Trailing 12 month basic EPS of ¥59.15 is below last year, even after a strong Q2, which shows the profit recovery is recent rather than broad based. The company is also carrying high debt, so investors need to judge whether current earnings are enough to support that balance sheet if conditions become tougher. The latest quarter calms some worries, but it does not erase them.
Review whether Medley’s high debt and recent share price swings are isolated issues or early signals of deeper fragility. Expose our risk analysis for Medley which shows 2 important warning signs.Take Charge Of Your Next Move
If Medley's sharp earnings rebound has you interested but cautious about the rich P/E and high debt, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch how the story develops. Once you hold Medley or any other stock, use the Portfolio Command Center to filter out market noise and get the key updates that matter for your positions. For a broader view on sentiment and potential catalysts, tap into the Community to see how other investors are thinking about opportunities and risks. This way you can spot emerging catalysts or early warning signs sooner and stay a step ahead of the market.
Seeking Fresh Alternatives Beyond Medley?
Markets move fast and the best breakout stories often fly under the radar for now. Scan fresh ideas before the crowd catches up and act now.
- Spot resilient setups that keep steadily building momentum by reviewing a curated pool of stocks in the 60 resilient stocks with low risk scores before they get fully priced in.
- Hunt for quality businesses that the market has not fully rewarded yet by scanning the hand picked 25 high quality undervalued stocks while the valuation gap still matters.
- Zero in on companies quietly compounding in the background with strong fundamentals using the carefully filtered 68 high quality undiscovered gems before attention and liquidity rush in.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com